会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • Treatment of parkinson's disease with oligonucleotides
    • 用寡核苷酸治疗帕金森病
    • US20050020530A1
    • 2005-01-27
    • US10937824
    • 2004-09-09
    • Jay Schneider
    • Jay Schneider
    • C12N15/09A61K31/7088A61K38/00A61K48/00A61P25/16C12N15/113
    • A61K31/711A61K38/00C12N15/1137C12N2310/152C12N2310/315
    • The present invention relates to a method of treatment of Parkinson's disease, and to the use of antisense oligonucleotides or triplex oligonucleotides introduced into targeted brain structures to decrease the function of brain circuits known to be overactive in the Parkinsonian brain. Antisense or triplex oligonucleotides are targeted to the internal globus pallidus and/or substantia nigra pars reticulata (SNr) where the expression of glutamic acid decarboxylase (GAD67, GAD65, or a combination of the two isoforms) is downregulated. The present invention also relates to a method of treatment of Parkinson's disease where antisense or triplex oligonucleotides are targeted to the internal globus pallidus and/or substantia nigra pars reticulata for the downregulation of glutamate receptors. The present invention further relates to a method of treatment of Parkinson's disease where antisense or triplex oligonucleotides are targeted to the thalamic motor nuclei for the downregulation of GABA receptors.
    • 本发明涉及治疗帕金森病的方法,以及引入靶向脑结构中的反义寡核苷酸或三链寡核苷酸的用途,以降低已知在帕金森病脑中过度活跃的脑电路的功能。 反义或三重寡核苷酸靶向内部苍白球和/或黑质浆果(SNr),其中谷氨酸脱羧酶(GAD67,GAD65或两种同种型的组合)的表达下调。 本发明还涉及一种治疗帕金森病的方法,其中反义或三重寡核苷酸针对内部苍白球和/或黑质黑质对谷氨酸受体的下调。 本发明还涉及治疗帕金森病的方法,其中反义或三重寡核苷酸靶向用于下调GABA受体的丘脑运动核。